JIANGSU HENGRUI MEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.61 CNY | +2.96% |
|
+9.43% | +0.84% |
| 04-26 | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
| 04-17 | Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Jiangsu Hengrui Medicine Co., Ltd.
bcaf3f6a23007758e250fce026d6e4.HaJDRLusSnTe6CxzEm7rQbmrlpsv8NIsDfZEtua0lg4.cPE3I8jKfgOR3HgjKzbaEePDzMFDxKJBObwyxI3npWVk7xA97eB6M62fHA~79ee7316b7474d44bca0459eaf75189c
Upcoming events on Jiangsu Hengrui Medicine Co., Ltd.
Past events on Jiangsu Hengrui Medicine Co., Ltd.
| 17/04/2024 | Q1 2024 Earnings Release |
| 17/04/2024 | Q4 2023 Earnings Release |
| 23/11/2023 06:00 | Extraordinary Shareholders Meeting |
| 25/10/2023 | Q3 2023 Earnings Release |
| 18/08/2023 | Q2 2023 Earnings Release |
| 07/06/2023 | Ex-dividend day for final dividend |
| 15/05/2023 07:00 | Annual General Meeting |
| 21/04/2023 | Q1 2023 Earnings Release |
| 21/04/2023 | Q4 2022 Earnings Release |
| 02/02/2023 01:00 | Extraordinary Shareholders Meeting |
| 28/10/2022 | Q3 2022 Earnings Release |
| 26/09/2022 03:20 | J.P. Morgan Global Healthcare Shanghai Conference |
| 08/09/2022 07:00 | Extraordinary Shareholders Meeting |
| 19/08/2022 | Interim 2022 Earnings Release |
| 04/07/2022 | Ex-dividend day for final dividend |
| 12/05/2022 07:00 | Annual General Meeting |
| 22/04/2022 | Q1 2022 Earnings Release |
| 22/04/2022 | FY 2021 Earnings Release |
| 27/12/2021 06:00 | Extraordinary Shareholders Meeting |
| 19/10/2021 | Q3 2021 Earnings Release |
Past dividends on Jiangsu Hengrui Medicine Co., Ltd.
| 07/06/2023 | Annual 0.16 CNY |
| 04/07/2022 | Annual 0.16 CNY |
| 09/06/2021 | Annual 0.2 CNY |
| 24/05/2020 | Annual 0.23 CNY |
| 27/03/2019 | Annual 0.22 CNY |
| 29/05/2018 | Annual 0.13 CNY |
| 30/05/2017 | Annual 0.135 CNY |
| 15/06/2016 | Annual 0.1 CNY |
| 14/06/2015 | Annual 0.1 CNY |
| 14/05/2014 | Annual 0.09 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 23 289 23 426 -0.59% | 27 735 28 579 -2.95% | 25 906 28 811 -10.08% | 21 275 22 104 -3.75% | 22 820 23 440 -2.65% | 26 261 |
|
EBITDA Million CNY | Released Forecast Spread | 6 796 5 947 14.27% | 7 483 7 533 -0.67% | 4 868 7 338 -33.67% | 4 717 4 689 0.6% | 5 666 5 011 13.08% | 6 068 |
|
EBIT Million CNY | Released Forecast Spread | 6 150 5 754 6.88% | 7 007 7 141 -1.87% | 4 665 6 719 -30.57% | 4 112 4 159 -1.13% | 4 910 4 744 3.49% | 5 643 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 6 056 5 922 2.25% | 6 895 7 349 -6.17% | 4 466 6 973 -35.95% | 3 968 4 530 -12.39% | 4 667 4 867 -4.1% | 5 825 |
|
Net income Million CNY | Released Forecast Spread | 5 328 5 211 2.24% | 6 328 6 414 -1.33% | 4 530 6 413 -29.36% | 3 906 4 143 -5.72% | 4 302 4 616 -6.79% | 5 384 |
|
EPS CNY | Released Forecast Spread | 0,83 0,82 1.62% | 0,99 1,01 -2.21% | 0,71 1,09 -35.02% | 0,61 0,65 -6.41% | 0,68 0,72 -6.14% | 0,86 |
| Announcement Date | 22/03/20 | 19/04/21 | 22/04/22 | 21/04/23 | 17/04/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 S1 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 11 309 11 345 -0.32% | 5 479 5 500 -0.39% | 4 750 6 143 -22.68% | 10 228 10 931 -6.43% | 5 717 6 016 -4.96% | 5 330 6 215 -14.25% | 11 047 12 352 -10.56% | 5 492 5 306 3.52% | 5 676 5 700 -0.42% | 11 168 11 500 -2.88% | 5 845 6 196 -5.65% | 5 806 6 199 -6.34% | 5 998 6 071 -1.21% | 6 246 | 12 193 | 6 587 | 6 704 | 6 088 | |
|
EBIT Million CNY | Released Forecast Spread | 1 366 1 467 -6.89% | 1 033 1 028 0.49% | 2 399 2 197 9.18% | 1 253 1 021 22.7% | 460 1 231 -62.62% | 1 713 2 339 -26.75% | 1 344 1 015 32.46% | 1 226 1 065 15.07% | 2 570 2 300 11.75% | 1 371 1 345 1.92% | 969 1 136 -14.73% | 1 636 1 175 39.21% | 1 241 | 2 807 | 1 415 | 1 338 | 1 285 | ||
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 986 1 022 -3.49% | 2 352 2 476 -5.01% | 1 182 898 31.61% | 434 1 415 -69.29% | 1 617 2 597 -37.75% | 1 188 1 232 -3.56% | 2 512 2 600 -3.37% | 1 300 1 493 -12.92% | 855 1 478 -42.16% | 1 435 | 2 952 | 1 583 | 1 573 | ||||||
|
Net income Million CNY | Released Forecast Spread | 2 662 2 718 -2.06% | 2 668 3 141 -15.07% | 882 949 -7.04% | 2 119 2 251 -5.85% | 1 054 849 24.1% | 733 1 172 -37.48% | 1 069 1 091 -1.97% | 2 308 2 340 -1.36% | 1 166 1 315 -11.37% | 829 1 169 -29.09% | 1 369 1 350 1.4% | 1 309 | 2 697 | 1 422 | 1 422 | ||||
|
EPS CNY | Released Forecast Spread | 0,19 0,22 -11.63% | 0,14 0,20 -28.65% | 0,17 0,18 -4.34% | 0,11 0,22 -49.08% | 0,19 0,19 0% | 0,17 0,18 -7.16% | 0,19 0,21 -7.32% | 0,13 0,17 -22.49% | 0,21 0,21 2.44% | 0,21 | 0,23 | 0,21 | 0,19 | ||||||
| Announcement Date | 31/07/20 | 19/08/21 | 22/04/22 | 19/08/22 | 19/08/22 | 28/10/22 | 21/04/23 | 21/04/23 | 21/04/23 | 18/08/23 | 18/08/23 | 25/10/23 | 17/04/24 | 17/04/24 | - | - | - | - | - |
More events
Past sector events for Jiangsu Hengrui Medicine Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600276 Stock
- Calendar Jiangsu Hengrui Medicine Co., Ltd.
